Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oncimmune Share News (ONC)
ONC Share
Price
ONC Share
News
ONC Share
Chat
ONC Share
Trades
ONC
Live RNS
ONC Share
Charts
ONC Broker
Ratings
ONC Directors
Deals
ONC Financial
Diary
ONC
Fundamentals
ONC Short
Positions
ONC
Media
ONC Company
Research
ONC Company
Timeline
- This share is currently suspended. It was suspended at a price of 1.2699
- There is currently no data for ONC
Oncimmune News
Oncimmune signs new contract with Alphabet division Verily
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the signing of a new commercial contract with Verily Life Sciences on Monday...
TRADING UPDATES: Novacyt gets UK approval; Nostra spuds Cypress well
(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:
Oncimmune's EarlyCDT Lung test granted approval by Ministry of Health for Aragon
(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that its EarlyCDT Lung test had been granted approval by the Ministry o...
TRADING UPDATES: Burford, Frenkel Topping expect contrasting results
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Oncimmune reports fresh research from Cedars-Sinai Covid study
(Sharecast News) - Oncimmune announced the publication of a paper arising from the research collaboration with Cedars-Sinai Medical Center in Los Ange...
Oncimmune study suggests antibodies spike following Covid infection
Oncimmune study suggests antibodies spike following Covid infection
Oncimmune shares up after multiple commercial contract wins
Oncimmune shares up after multiple commercial contract wins
Oncimmune signs new commercial contracts
(Sharecast News) - Oncimmune Holdings announced on Tuesday that it has signed further commercial contracts within its 'ImmunoINSIGHTS' pharma services...
Follow the stocks
